|
May 2
|
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
May 1
|
CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023
|
|
May 1
|
CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|